Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Caloric Restriction in Obesity and Type 2 Diabetes (CRESO2)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Mario Negri Institute for Pharmacological Research
Sponsor:
Collaborator:
Istituto Superiore di Sanità
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research
ClinicalTrials.gov Identifier:
NCT01930136
First received: August 23, 2013
Last updated: September 16, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2017
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)